On Tuesday, 120 companies achieved new lows for the year.
June 29, 12:05 PM
Galera Therapeutics Inc (NASDAQ:GRTX) announced results from the open-label Phase 1 stage of the GRECO-1 trial of rucosopasem in combination with…
Galera Therapeutics Announces On June 8, Co. Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
June 10, 4:22 PM
May 27, 11:36 AM
May 27, 8:25 AM
B of A Securities analyst Tazeen Ahmad downgrades Galera Therapeutics (NASDAQ:GRTX) from Neutral to Underperform and announces $2 price target.
Galera Announces Oral Presentation At 2022 American Society Of Clinical Oncology Annual Meeting Detailing Results From Phase 3 ROMAN Trial Of Avasopasem
May 26, 5:04 PM
Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform
March 23, 5:34 PM
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the press release, Q4 earnings came out 2 days ago.
Galera Therapeutics Subsidiary Galera Labs Granted U.S. Patent #11,246,950 ‘ Combination cancer immunotherapy with pentaaza macrocyclic ring complex’
February 15, 10:23 AM
View patent here